NDC 0597-0003
Aptivus
Tipranavir
Aptivus is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Tipranavir.
| Product ID | 0597-0003_3d3e31e9-8b19-4d95-ac47-fe42aee61cde |
| NDC | 0597-0003 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Aptivus |
| Generic Name | Tipranavir |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 2005-07-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021814 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | TIPRANAVIR |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0597-0003-02
120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-02)
| Marketing Start Date | 2005-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0597-0003-02 [00597000302]
Aptivus CAPSULE, LIQUID FILLED
| Marketing Category | NDA |
| Application Number | NDA021814 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-07-01 |
NDC 0597-0003-01 [00597000301]
Aptivus CAPSULE, LIQUID FILLED
| Marketing Category | NDA |
| Application Number | NDA021814 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-12-10 |
| Marketing End Date | 2010-05-20 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| TIPRANAVIR | 250 mg/1 |
OpenFDA Data
| SPL SET ID: | 08982e49-d2eb-4b25-b01a-1be52fd669ef |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- HIV Protease Inhibitors [MoA]
- Protease Inhibitor [EPC]
NDC Crossover Matching brand name "Aptivus" or generic name "Tipranavir"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0002 | Aptivus | tipranavir |
| 0597-0003 | Aptivus | tipranavir |
Trademark Results [Aptivus]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 APTIVUS 78209408 not registered Dead/Abandoned |
Boehringer Ingelheim International GmbH 2003-01-31 |
 APTIVUS 78148660 2750405 Live/Registered |
Boehringer Ingelheim International GmbH 2002-07-30 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.